|
COURSE DESCRIPTION
Release Date: August 7, 2007
Expiration Date: August 7, 2008
Program Overview
This Web cast is a presentation of an important symposium presented at the 2007 11th World Congress on Cancers of the Skin in Amsterdam. World renowned melanoma experts review currently available therapies for metastatic melanoma as well as a large number of emerging immunotherapies and targeted agents being evaluated in clinical trials.
Target Audience
This educational activity is intended for dermatologists,
surgical oncologists, medical oncologists and other
practitioners involved in the management and treatment
of melanoma.
Educational Objectives
After viewing the Web cast, the participant will be able to:
- Discuss the role of chemotherapy and biochemotherapy in the treatment of advanced melanoma.
- Identify the indications for the utilization of the novel anti-CTLA4 agents under investigation for the management of metastatic melanoma.
- Summarize and review the safety and efficacy of anti-CTLA4 antibody therapy in advanced melanoma.
- Discuss the emerging role for peptide vaccine therapy in advanced melanoma.
- Describe ongoing clinical trials investigating the role of vaccines and cytokines in the adjuvant setting.
- Discuss the evolving role for targeted therapies for advanced melanoma.
- Describe and discuss the potential for optimal integration of these novel strategies into the current algorithm of melanoma care.
Continuing Medical Education
Physicians:
Imedex Accreditation Services, LLC (Imedex) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex® designates this educational activity for a maximum 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Credits will be awarded upon completion and submission of the self-assessment questions, evaluation form, and CME credit request form to:
Imedex®
4325 Alexander Drive
Alpharetta, GA 30022
Fax: +1(770) 751 7334
Deadline for CME Credit submission: August 7, 2008
Unapproved and Investigational Uses of Drugs and Devices
This Web cast may contain information about experimental and other uses of drugs or devices that are not currently approved by the Food and Drug Administration (FDA) and/or other national regulatory agencies in the United States and other countries. Participants in the United States are encouraged to consult the FDA-approved product labeling for any drug or device mentioned in this program before use. Participants from other countries should consult with their respective regulatory authorities.
The opinions expressed in this Web cast are the opinions of the authors and do not necessarily reflect the opinions of Imedex ® or Merck.
Event Organizer
Imedex®
4325 Alexander Drive
Alpharetta, GA 30022
Fax: +1(770) 751 7334
Faculty Disclosure
As an accredited provider of continuing medical education, Imedex Accreditation Services, LLC is required to ask speakers to disclose any real or apparent conflict of interest they may have as related to the contents of their presentation(s). The existence of commercial or financial interests of speakers related to the subject matter of their presentation(s) should not be construed as implying bias or decreasing the value of their presentation(s). However, disclosure should help participants form their own judgments.
All speakers were independently selected by the organizing committee. Those speakers who disclosed affiliations or financial interests with the commercial organizations involved with products, to which they may refer, are listed below.
1=grant/research support 2=consultant 3=speaker’s bureau 4=stock shareholder 5=other support
| Alexander M.M. Eggermont, MD, PhD |
Bayer2, Boehringer-Ingelheim2, GlazoSmithKline-Bio2, Onyx2, sanofi pasteur2, Schering-Plough1,2, Synta2
|
| Jurgen C. Becker, MD, PhD |
Merek1,2, Novartis2
|
| Celeste Lebbe, MD, PhD |
Novartis1,5
|
| Mark R. Middleton, PhD, MRCP |
AstraZeneca1, Schering-Plough1,2 |
The following speakers have reported an affiliation with the supporters of this conference:
| Alexander M.M. Eggermont, MD, PhD |
Bristol-Myers Squibb2, Genta2
|
| Celeste Lebbe, MD, PhD |
Bristol-Myers Squibb5, Genta1,5 |
Imedex Accreditation Services, LLC Staff Disclosure of Financial Relationships
All Imedex® staff members who are in a position to control the content of this activity have no financial relationships with any commercial interests that are relevant to this activity.
Imedex Accreditation Services, LLC is an independent provider of continuing medical education. Imedex Accreditation Services, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA has regulatory authority.
©2007 Imedex Accreditation Services, LLC. All rights reserved. Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
Systems Requirements
- Windows
98/NT/2000/XP/Vista
or
Mac
OS
9/X
- Internet
Browser
(Microsoft
Internet
Explorer
5.5
or
later,
Firefox,
Netscape,
Safari,
etc.)
- Adobe
Flash
player
8
- Click
here
to
download
- High-speed
Internet
connection
- Monitor
settings:
High
color
at
800
x
600
pixels
- Sound
card
and
speakers
- Evaluation
forms
require
Adobe
Acrobat
Reader
- Click
here
to
download
For questions or comments regarding the content or performance of this Web cast please contact Imedex at meetings@imedex.com.
|
